
Company
Moderna ($MRNA)
- Biotech
- Latest funding:
- $590M · Series C+ · Apr 2025
Overview
Develops mRNA medicines using a platform for designing, researching, and testing mRNA, with a focus on addressing infectious and serious diseases.
Part of the Boston ecosystem
Related
Timeline
Funding Roundmodernatx.com ↗
BARDA contract for pandemic-preparedness mRNA vaccines.
Funding Roundmodernatx.com ↗
Founded 2010 in Cambridge MA; mRNA platform.